CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer

por Liang, Yuan-ke, Deng, Ze-kun-, Chen, Mu-tong, Qiu, Si-qi, Xiao, Ying-sheng, Qi, Yu-zhu, Xie, Qin, Wang, Zheng-hao, Jia, Shi-cheng, Zeng, De, Lin, Hao-yu
Publicado 2021

MiR-221/222 promote epithelial-mesenchymal transition by targeting Notch3 in breast cancer cell lines

por Liang, Yuan-Ke, Lin, Hao-Yu, Dou, Xiao-Wei, Chen, Min, Wei, Xiao-Long, Zhang, Yong-Qu, Wu, Yang, Chen, Chun-Fa, Bai, Jing-Wen, Xiao, Ying-Sheng, Qi, Yu-Zhu, Kruyt, Frank A. E., Zhang, Guo-Jun
Publicado 2018